Halozyme Therapeutics (HALO) Tops Q2 EPS by 14c, Offers Guidance

Go back to Halozyme Therapeutics (HALO) Tops Q2 EPS by 14c, Offers Guidance
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 108.44 --0 (-0%)
Previous Close $108.44    52 Week High $18.39 
Open $108.44    52 Week Low $6.96 
Day High $108.44    P/E N/A 
Day Low $108.44    EPS $-0.58 
Volume 44,889